Pharmacokinetics of ceftriaxone after intravenous, intramuscular and subcutaneous administration to domestic cats

Journal of Veterinary Pharmacology and Therapeutics

Volumn 30, Issue 4, 2007, Pages 345-352

  Albarellos, G A ^a   Kreil, V E ^a   Landoni, M F ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE;

ANIMAL EXPERIMENT; ARTICLE; CAT; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISPOSITION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; CATS; CEFTRIAXONE; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; MALE; MICROBIAL SENSITIVITY TESTS;

ESCHERICHIA COLI; FELIS CATUS; NEGIBACTERIA; POSIBACTERIA;

EID: 34347392908     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2007.00871.x     Document Type: Article

References (51)

1. Albarellos, G.A., Bonafine, R.R., Kreil, V.E., Ambros, L.A., Montoya, L. Hallu, R.E. (2003) A non-surgical jugular catheterization technique for multiple blood sampling in cats. Laboratory Animals, 37, 188 192.
2. Angehrn, P., Hohl, P., Hubschwerlen, C., Page, M. Then, R. (1992) Antibacterial properties of Ro 40-6890, a broad-spectrum cephalosporin, and its novel orally absorbable ester, Ro 41-3399. Antimicrobial Agents and Chemotherapy, 36, 2825 2834.
3. Baggot, J.D. (2001) The Physiological Basis of Veterinary Clinical Pharmacology. Blackwell Publishing Ltd, Oxford, UK.
4. Bennet, J.V., Brodie, J.L., Bennet, E.J. Kirby, W.M. (1966) Simplified accurate method for antibiotic assay of clinical specimens. Applied Microbiology, 14, 170 177.
5. Bourget, P., Fernandez, H., Quinquis, V. Deluis, C. (1993) Pharmacokinetics and protein binding of ceftriaxone during pregnancy. Antimicrobial Agents and Chemotherapy, 37, 54 59.
6. Casellas, J.M., Tomé, G., Bantar, C., Bertolini, P., Blázquez, N., Borda, N., Couto, E., Cudmani, N., Guerrera, J., Juárez, M.J., López, T., Littvik, A., Méndez, E., Notario, R., Ponce, G., Quinteros, M., Salamone, F., Sparo, M., Sutich, E., Vaylet, S. Wolff, L. (2003) Argentinean collaborative multicenter study on the in vitro comparative activity of piperacillin-tazobactam against selected bacterial isolates recovered from hospitalized patients. Diagnostic Microbiology and Infectious Disease, 47, 527 537.
7. CLSI (2006a) (former NCCLS) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard. Document M07-A5. CLSI, Wayne, PA.
8. CLSI (2006b) (former NCCLS) Performance Standards for Antimicrobial Susceptibility Testing. Supplemental tables M100-S16. CLSI, Wayne, PA.
9. Craig, W.A. (1998) Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clinical Infectious Diseases, 26, 1 12.
10. Dardi, M.S., Sharma, S.K. Srivastava, A.K. (2004) Pharmacokinetics and dosage regimen of ceftriaxone in buffalo calves. Veterinary Research Communications, 28, 331 338.
11. Deguchi, E. Akuzawa, M. (1997) Renal clearance or endogenous creatinine, urea, sodium, and potassium in normal cats and cats with chronic renal failure. Journal of Veterinary Medical Science, 59, 509 512.
12. Drusano, G.L. (1988) Role of pharmacokinetics in the outcome of infections. Antimicrobial Agents and Chemotherapy, 32, 289 297.
13. Frimodt-Møller, N., Bentzon, M.W. Thomsen, V.F. (1986) Experimental infection with Streptococcus pneumoniae in mice: correlation of in vitro activity and pharmacokinetic parameters with in vivo effect for 14 cephalosporins. The Journal of Infectious Diseases, 154, 511 517.
14. Gardner, S.Y. Aucoin, D.P. (1994) Pharmacokinetics of ceftriaxone in mares. Journal of Veterinary Pharmacology and Therapeutics, 17, 155 156.
15. Giacometti, A., Cirioni, O., Kamysz, W., D'Amato, G., Silvestri, C., Licci, A., Nadolski, P., Riva, A., Lukasiak, J. Scalise, G. (2005) In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. International Journal of Antimicrobial Agents, 26, 235 240.
16. Gibaldi, M. Perrier, D. (1982) Pharmacokinetics, 2nd edn. Marcel Dekker Inc., New York.
17. Granero, L., Santiago, M., Cano, J., Machado, A. Peris, J.E. (1995) Analysis of ceftriaxone and ceftazidime distribution in cerebrospinal fluid of and cerebral extracellular space in awake rats by in vivo microdialysis. Antimicrobial Agents and Chemotherapy, 39, 2728 2731.
18. Granich, G.G. Krogstad, D.J. (1987) Ion pair high-performance liquid chromatographic assay for ceftriaxone. Antimicrobial Agents and Chemotherapy, 31, 385 388.
19. Guerrini, V.H., Filippich, L.J., Cao, G.R., English, P.B. Bourne, D.W. (1985) Pharmacokinetics of cefaronide, ceftriaxone and cofoperazone in sheep. Journal of Veterinary Pharmacology and Therapeutics, 8, 120 127.
20. Gunderson, B.W., Ross, G.H., Ibrahim, K.H. Rotschafer, J.C. (2001) What do we really know about antibiotic pharmacodynamics Pharmacotherapy, 21, 302 318.
21. Ismal, M.M. (2005) Pharmacokinetics, urinary and mammary excretion of ceftriaxone in lactating goats. Journal of Veterinary Medicine A, 52, 354 358.
22. Johal, B. Srivastava, A.K. (1999) Disposition kinetics and dosage regimen of ceftriaxone in crossbred calves. Acta Veterinaria Hungarica, 47, 243 248.
23. Joynt, G.M., Lipman, J., Gomersall, C.D., Young, R.J., Wong, E.L.Y. Gin, T. (2001) The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients. Journal of Antimicrobial Chemotherapy, 47, 421 429.
24. Kohlhepp, S.J., Gilbert, D.N. Leggett, J.E. (1998) Influence of assay methodology on the measurement of free serum ceftriaxone concentrations. Antimicrobial Agents and Chemotherapy, 42, 2259 2261.
25. Kovar, A., DallaCosta, T. Derendorf, H. (1997) Comparison of plasma and free tissue levels of ceftriaxone in rats by microdialysis. Journal of Pharmaceutical Sciences, 86, 52 56.
26. Leggett, J.E., Ebert, S., Fantin, B. Craig, W.A. (1991) Comparative dose-effect relations at several dosing intervals for beta-lactam, aminoglycoside and quinolone antibiotics against gram-negative bacilli in murine thigh-infection and pneumonitis models. Scandinavian Journal of Infectious Diseases, 74, 179 184.
27. Li, T., Qiao, G.L., Hu, G.Z., Meng, F.D., Qiu, Y.S., Zhang, X.Y., Guo, W.X., Yie, H.L., Li, S.F. Li, S.Y. (1995) Comparative plasma and tissue pharmacokinetics and drug residue profiles of different chemotherapeutants in fowls and rabbits. Journal of Veterinary Pharmacology and Therapeutics, 18, 260 273.
28. Martin, C., Ragni, J., Lokiec, F., Guillen, J.C., Auge, A., Pecking, M. Gouin, F. (1992) Pharmacokinetics and tissue penetration of a single dose of ceftriaxone (1000 milligrams intravenously) for antibiotic prophylaxis in thoracic surgery. Antimicrobial Agents and Chemotherapy, 36, 2804 2807.
29. Matsui, H., Komiya, M., Ikeda, C. Tachibana, A. (1984) Comparative pharmacokinetics of YM-13115, ceftriaxone, and ceftazidime in rats, dogs, and Rhesus monkeys. Antimicrobial Agents and Chemotherapy, 26, 204 207.
30. McKellar, Q.A., Sanchez Bruni, S.F. Jones, D.G. (2004) Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics, 27, 503 514.
31. Merle-Melet, M., Seta, N., Farinotti, R. Carbon, C. (1989) Reduction in biliary excretion of ceftriaxone by diclofenac in rabbits. Antimicrobial Agents and Chemotherapy, 33, 1506 1510.
32. Meyers, B.R., Jacobson, E.S., Srulevitch, J. Hirschman, S.Z. (1983) Crossover study of the pharmacokinetics of ceftriaxone administered intravenously or intramuscularly to healthy volunteers. Antimicrobial Agents and Chemotherapy, 24, 812 814.
33. Patel, I.H., Chen, S., Parsonnet, M., Hackman, M.R., Brooks, M.A., Konikoff, J. Kaplan, S.A. (1981) Pharmacokinetics of ceftriaxone in humans. Antimicrobial Agents and Chemotherapy, 20, 634 641.
34. Plumb, D.C. (2005) Veterinary Drug Handbook, 5th edn. Blackwell Publishing Ltd, Ames, IA.
35. Pollock, A.A., Tee, P.E., Patel, I.H., Spicehandler, J., Simberkoff, M.S. Rahal, J.J. (1982) Pharmacokinetic characteristics of intravenous ceftriaxone in normal adults. Antimicrobial Agents and Chemotherapy, 22, 816 823.
36. Popick, A.C., Crouthamel, W.G. Bekersky, I. (1987) Plasma protein binding of ceftriaxone. Xenobiotica, 17, 1139 1145.
37. Rebuelto, M., Albarellos, G., Ambros, L., Kreil, V., Montoya, L., Bonafine, R., Otero, P. Hallu, R. (2002) Pharmacokinetics of ceftriaxone administered by the intravenous, intramuscular or subcutaneous routes to dogs. Journal of Veterinary Pharmacology and Therapeutics, 25, 73 76.
38. Rhomberg, P.R., Jones, R.N., Sader, H.S. The MYSTIC Programme (US) Study Group (2004) Results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme: report of the 2001 data from 15 United States medical centres. International Journal of Antimicrobial Agents, 23, 52 59.
39. Ringger, N.C., Pearson, E.G., Gronwall, R. Kohlepp, S.J. (1996) Pharmacokinetics of ceftriaxone in healthy horses. Equine Veterinary Journal, 28, 476 479.
40. Ringger, N.C., Brown, M.P., Kohlepp, S.J., Gronwall, R.R. Merritt, K. (1998) Pharmacokinetics of ceftriaxone in neonatal foals. Equine Veterinary Journal, 30, 163 165.
41. Sakata, Y., McCracken, G.H., Thomas, M.L. Olsen, K.D. (1984) Pharmacokinetics and therapeutic efficacy of imipenem, ceftazidime, and ceftriaxone in experimental meningitis due to an ampicillin- and chloramphenicol-resistant strain of Haemophilus influenzae type b. Antimicrobial Agents and Chemotherapy, 25, 29 32.
42. Schwartz, G. (1978) Estimating the dimension of a model. Annals of Statistics, 6, 461 464.
43. Seddon, M., Wise, R., Gillett, A.P. Livingston, R. (1980) Pharmacokinetics of Ro-13-9904, a broad-spectrum cephalosporin. Antimicrobial Agents and Chemotherapy, 18, 240 242.
44. Soback, S. Ziv, G. (1988) Pharmacokinetics and bioavailability of ceftriaxone administered intravenously and intramuscularly to calves. American Journal of Veterinary Research, 49, 535 538.
45. Sumano, L.H., del Hevia, P.C., Ruiz, S.A.L., Vazquez, S.A. Zamora, M.A. (1998) Clinical efficacy and pharmacokinetics of low doses of ceftriaxone in healthy pigs and pigs with respiratory disease. The Pig Journal, 42, 33 42.
46. Ti, T.Y., Fortin, L., Kreeft, J.H., East, D.S., Ogilvie, R.I. Somerville, P.J. (1984) Kinetic disposition of intravenous ceftriaxone in normal subjects and patients with renal failure on hemodialysis or peritoneal dialysis. Antimicrobial Agents and Chemotherapy, 25, 83 87.
47. Toutain, P.L., Del Castillo, J.R.E. Bousquet-Mélou, A. (2002) The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics. Research in Veterinary Science, 73, 105 114.
48. Turnidge, J.D. (1998) The pharmacodynamics of β-lactams. Clinical Infectious Diseases, 27, 10 22.
49. Vogelman, B., Gudmundsson, S., Leggett, J., Turnidge, J., Ebert, S. Craig, W.A. (1988) Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. The Journal of Infectious Diseases, 158, 831 847.
50. Yamaoka, K., Nakagawa, T. Uno, T. (1978) Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. Journal of Pharmacokinetics and Biopharmaceutics, 6, 165 175.
51. Zhou, H.H., Chan, Y.P.M., Arnold, K., Sun, M. (1985) Single-dose pharmacokinetics of ceftriaxone in healthy Chinese adults. Antimicrobial Agents and Chemotherapy, 27, 192 196.